Disclosed herein are compounds of the general Formula (I), and methods of synthesizing substituted bicyclo[1.1.1 jpentanes. The synthetic methods described herein use a [1.1.1]propellane, a Group VIII transition metal compound, a hydride source and a reagent that can contribute a substituent to form a substituted bicyclo[1.1.1]pentane, such as a compound of the general Formula (I).

Disclosed herein are compounds of the general Formula (I), and methods of synthesizing substituted bicyclo[1.1.1 jpentanes. The synthetic methods described herein use a [1.1.1]propellane, a Group VIII transition metal compound, a hydride source and a reagent that can contribute a substituent to form a substituted bicyclo[1.1.1]pentane, such as a compound of the general Formula (I).

A manufacturing method of an amine compound including obtaining a reaction solution containing an aldehyde compound by reacting a compound represented by Formula (a1) or (a2) with hydrogen and carbon monoxide in the presence of a metal compound of groups 8 to 10 and a phosphorus compound, neutralizing the reaction, purifying an aldehyde compound by distilling the neutralized reaction solution, and reacting the aldehyde compound with ammonia and with hydrogen in the presence of a catalyst to obtain an amine compound, wherein the phosphorus compound is represented by the Formula (R.sup.1O).sub.3P, and the base compound is at least one selected from carbonate and hydrogen carbonate of metals of group I and carbonate and hydrogen carbonate of metals of group II, ##STR00001##
and wherein the neutralizing the reaction solution is performed within a temperature range of 40 C. to 50 C.

A manufacturing method of an amine compound including obtaining a reaction solution containing an aldehyde compound by reacting a compound represented by Formula (a1) or (a2) with hydrogen and carbon monoxide in the presence of a metal compound of groups 8 to 10 and a phosphorus compound, neutralizing the reaction, purifying an aldehyde compound by distilling the neutralized reaction solution, and reacting the aldehyde compound with ammonia and with hydrogen in the presence of a catalyst to obtain an amine compound, wherein the phosphorus compound is represented by the Formula (R.sup.1O).sub.3P, and the base compound is at least one selected from carbonate and hydrogen carbonate of metals of group I and carbonate and hydrogen carbonate of metals of group II, ##STR00001##
and wherein the neutralizing the reaction solution is performed within a temperature range of 40 C. to 50 C.

A manufacturing method of an isocyanate compound including obtaining a reaction solution containing an aldehyde compound by reacting a compound represented by Formula (a1) or (a2) with hydrogen and carbon monoxide in the presence of a metal compound of groups 8 to 10 and a phosphorus compound, neutralizing the reaction solution, purifying an aldehyde compound by distilling the neutralized reaction solution, reacting the aldehyde compound with ammonia and with hydrogen in the presence of a catalyst to obtain an amine compound; and reacting the amine compound with a carbonylating agent to obtain an isocyanate compound, wherein the phosphorus compound is represented by the Formula (R.sup.1O).sub.3P, and the base compound is at least one selected from carbonate and hydrogen carbonate of metals of group I and carbonate and hydrogen carbonate of metals of group II, ##STR00001##
wherein the neutralizing the reaction solution is performed within a temperature range of 40 C. to 50 C.

A manufacturing method of an isocyanate compound including obtaining a reaction solution containing an aldehyde compound by reacting a compound represented by Formula (a1) or (a2) with hydrogen and carbon monoxide in the presence of a metal compound of groups 8 to 10 and a phosphorus compound, neutralizing the reaction solution, purifying an aldehyde compound by distilling the neutralized reaction solution, reacting the aldehyde compound with ammonia and with hydrogen in the presence of a catalyst to obtain an amine compound; and reacting the amine compound with a carbonylating agent to obtain an isocyanate compound, wherein the phosphorus compound is represented by the Formula (R.sup.1O).sub.3P, and the base compound is at least one selected from carbonate and hydrogen carbonate of metals of group I and carbonate and hydrogen carbonate of metals of group II, ##STR00001##
wherein the neutralizing the reaction solution is performed within a temperature range of 40 C. to 50 C.

Provided herein are compounds of formula I: ##STR00001##
and salts thereof and compositions and uses thereof. The compounds are useful as inhibitors of LSD1. Also included are pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various LSD1-mediated disorders.

The present invention provides compositions and methods for detecting GluA1, as a subunit protein and/or as a GluA1-containing, GluA2-lacking AMPAR complex. The invention further provides composition and methods for detecting and/or diagnosing PTSD. The invention further relates to compositions that can be detected using radiological imaging techniques, and processes for performing such imaging techniques using the compositions, to identify elevated GluA1 expression or activity in a subject, which is a biological marker of PTSD.

The present invention provides compositions and methods for detecting GluA1, as a subunit protein and/or as a GluA1-containing, GluA2-lacking AMPAR complex. The invention further provides composition and methods for detecting and/or diagnosing PTSD. The invention further relates to compositions that can be detected using radiological imaging techniques, and processes for performing such imaging techniques using the compositions, to identify elevated GluA1 expression or activity in a subject, which is a biological marker of PTSD.

The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.